🇺🇸 Soy Supplement in United States
24 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 24
Most-reported reactions
- Flushing — 4 reports (16.67%)
- Injection Site Pain — 3 reports (12.5%)
- Pain — 3 reports (12.5%)
- Back Pain — 2 reports (8.33%)
- Hypersensitivity — 2 reports (8.33%)
- Hypoaesthesia — 2 reports (8.33%)
- Incorrect Dose Administered — 2 reports (8.33%)
- Insomnia — 2 reports (8.33%)
- Memory Impairment — 2 reports (8.33%)
- Paraesthesia — 2 reports (8.33%)
Other Women's Health approved in United States
Frequently asked questions
Is Soy Supplement approved in United States?
Soy Supplement does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Soy Supplement in United States?
VA Office of Research and Development is the originator. The local marketing authorisation holder may differ — check the official source linked above.